Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study

PURPOSE: Treatment of medulloblastoma has evolved from surgery and radiotherapy to contemporary multimodal regimens. However, the impact on long-term health outcomes remains unknown. METHODS: Cumulative incidence of late mortality (5 or more years from diagnosis), subsequent neoplasms (SNs), and chr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Salloum, Ralph, Chen, Yan, Yasui, Yutaka, Packer, Roger, Leisenring, Wendy, Wells, Elizabeth, King, Allison, Howell, Rebecca, Gibson, Todd M., Krull, Kevin R., Robison, Leslie L., Oeffinger, Kevin C., Fouladi, Maryam, Armstrong, Gregory T.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2019
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424138/
https://ncbi.nlm.nih.gov/pubmed/30730781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00969
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars